US stock market closing: The roller coaster trend of the interest rate night is alarming, and the three major indexes closed slightly lower.
① Most China concept stocks in hot demand fell, with the Nasdaq China Golden Dragon Index dropping 0.86%; ② Space concept stock Intuitive Machines surged 38%; ③ The Federal Reserve cut interest rates dramatically by 50 basis points, but Powell claimed not to be eager to ease policy; ④ Boeing will implement unpaid leave measures in the coming days.
AstraZeneca Fasenra Gains Additional Indication
AstraZeneca's Asthma Drug Gets FDA Approval For Rare Disease Of Blood Vessel Inflammation
GlaxoSmithKline has reached settlements regarding two lawsuits in California related to the heartburn medication Zantac.
On September 18, GlaxoSmithKline, a pharmaceutical company in the united kingdom, announced that it has agreed to settle two lawsuits filed in California alleging that its discontinued heartburn drug Zantac could cause cancer. GlaxoSmithKline stated in a statement that the company does not admit any responsibility in these two settlements. Over the past 12 months, GlaxoSmithKline has resolved a series of lawsuits related to Zantac, including several in California.
GSK Settles Two California Lawsuits Related to Zantac
Roivant Flips a Skin Drug to Organon -- Barrons.com